Greater Anxiety Linked With Unmet Information Needs in Precancerous Oral Lesions
the Cancer Therapy Advisor take:
Greater anxiety levels were associated with high degrees of unmet information need in patients with precancerous oral lesions, according to an article published online in the European Journal of Cancer Care.
Participants in this study included 106 individuals seen at the otolaryngology outpatient department at a single medical center in central Taiwan for precancerous oral lesions. The patients completed structured questionnaires that aimed to measure their state anxiety levels, attitudes towards cancer prevention, and need for information.
Results showed the most common unmet information needs among the patients were about obtaining their test results promptly.
Furthermore, higher levels of unmet information needs were more common in patients with precancerous oral lesions who reported high levels of state anxiety, had a long duration of time since quitting betel nut chewing, and had no history of oral cancer.
Patients with unmet information needs were more likely to have higher levels of anxiety about precancerous lesions than those who had their information needs met.
The study suggests improvements be made in health education and individual counseling in order to satisfy information needs of patients.
Greater anxiety levels were associated with high degrees of unmet information need in patients with precancerous oral lesions.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- A Vegan Diet and Cancer
- As HPV-Related Cancer Rates Climb, Experts Scrutinize Barriers to HPV Vaccination
- Bowel Preparation for Colorectal Cancer Screening: Improving Outcomes
- Tool for Assessing Frailty Predicts Survival in Newly Diagnosed Multiple Myeloma
- Analysis Supports Flat Dose of Nivolumab 480 mg Every 4 Weeks
- FDA-Approved Breast Cancer Drug Treatments
- A Trained Dog Smells Early-Stage Lung Cancer With a High Degree of Accuracy
- FDA-Approved Prostate Cancer Drug Treatments
- FDA-Approved Colorectal Cancer Drug Treatments
- Synthetic or Plant-Based Cannabis for Symptom Relief in Patients With Cancer: Do We Have Any Evidence?
- Role of miR-125a-5p Clarified in Bladder Cancer
- Bladder Cancer Clinical Features Linked to EGFR and HER-2 Expression
- Ponatinib Tops Bosutinib for Third-Line Treatment of CML in a Comparative Analysis
- A Vegan Diet and Cancer
- The Optimal Neoadjuvant Regimen of Checkpoint Inhibitors in High-Risk Melanoma Is Unclear